Related Experiment Video
Updated: Oct 7, 2025

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury
Sherry G Mansour1,2, Pavan K Bhatraju3,4, Steven G Coca5
1Clinical Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Insights
A higher angiopoietin-1 to angiopoietin-2 ratio indicates better vessel stability, significantly reducing risks of chronic kidney disease progression, heart failure, and mortality after acute kidney injury.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Long-term consequences of acute kidney injury (AKI) are not fully understood.
- Vessel instability, a result of endothelial injury, may be a common factor in chronic kidney disease (CKD) and heart failure development.
- Angiopoietins are key regulators of vascular homeostasis.
Purpose of the Study:
- To determine if plasma angiopoietin levels correlate with CKD progression and heart failure admissions post-hospitalization.
- To investigate the association between the angiopoietin-1 (Angpt-1) to angiopoietin-2 (Angpt-2) ratio and adverse outcomes in patients with and without AKI.
- To analyze the prognostic value of the Angpt-1:Angpt-2 balance in predicting CKD progression, heart failure, and mortality.
Main Methods:
- Prospective cohort study of 1503 hospitalized patients.
- Measurement of plasma angiopoietins (Angpt-1 and Angpt-2) three months post-discharge.
- Evaluation of associations between the Angpt-1:Angpt-2 ratio and outcomes including CKD progression, heart failure, and all-cause mortality.
Main Results:
- The highest quartile of the Angpt-1:Angpt-2 ratio was linked to a 72% lower risk of CKD progression and 94% lower risk of heart failure in AKI patients.
- Among AKI patients, a higher Angpt-1:Angpt-2 ratio was associated with an 82% reduction in mortality.
- In patients without AKI, the highest Angpt-1:Angpt-2 ratio correlated with significantly lower risks of heart failure and mortality, but not CKD progression.
Conclusions:
- A higher angiopoietin-1 to angiopoietin-2 ratio is a strong predictor of reduced CKD progression, heart failure, and mortality, particularly in patients with a history of AKI.
- Vascular homeostasis, as indicated by the Angpt-1:Angpt-2 balance, plays a crucial role in long-term outcomes after AKI.
- The Angpt-1:Angpt-2 ratio holds potential as a biomarker for assessing cardiovascular and renal risk post-hospitalization.
Background:
The mechanisms underlying long-term sequelae after AKI remain unclear. Vessel instability, an early response to endothelial injury, may reflect a shared mechanism and early trigger for CKD and heart failure.
Methods:
To investigate whether plasma angiopoietins, markers of vessel homeostasis, are associated with CKD progression and heart failure admissions after hospitalization in patients with and without AKI, we conducted a prospective cohort study to analyze the balance between angiopoietin-1 (Angpt-1), which maintains vessel stability, and angiopoietin-2 (Angpt-2), which increases vessel destabilization. Three months after discharge, we evaluated the associations between angiopoietins and development of the primary outcomes of CKD progression and heart failure and the secondary outcome of all-cause mortality 3 months after discharge or later.
Results:
Median age for the 1503 participants was 65.8 years; 746 (50%) had AKI. Compared with the lowest quartile, the highest quartile of the Angpt-1:Angpt-2 ratio was associated with 72% lower risk of CKD progression (adjusted hazard ratio [aHR], 0.28; 95% confidence interval [CI], 0.15 to 0.51), 94% lower risk of heart failure (aHR, 0.06; 95% CI, 0.02 to 0.15), and 82% lower risk of mortality (aHR, 0.18; 95% CI, 0.09 to 0.35) for those with AKI. Among those without AKI, the highest quartile of Angpt-1:Angpt-2 ratio was associated with 71% lower risk of heart failure (aHR, 0.29; 95% CI, 0.12 to 0.69) and 68% less mortality (aHR, 0.32; 95% CI, 0.15 to 0.68). There were no associations with CKD progression.
Conclusions:
A higher Angpt-1:Angpt-2 ratio was strongly associated with less CKD progression, heart failure, and mortality in the setting of AKI.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

